查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1620752

臨床前影像市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床前影像市場價值為24.8億美元，預計到2024年將達到26億美元，複合年成長率為4.91%，到2030年將達到34.8億美元。

臨床前成像是藥物開發過程的重要組成部分，通常用於研究疾病模型、評估候選藥物的功效以及了解體內生物過程。其範圍包括各種顯像模式，如 MRI、PET、CT、光學和超音波，提供轉化研究所需的詳細空間和時間資料。臨床前影像的需求在於其能夠透過提供高通量、可量化、非侵入性的動物模型研究工具來加速藥物發現過程。主要應用於腫瘤學、神經學、心臟病學和感染疾病學。

主要市場統計
基準年[2023] 24.8億美元
預測年份 [2024] 26億美元
預測年份 [2030] 34.8億美元
複合年成長率（%） 4.91%

臨床前影像市場的發展主要受到成像技術進步、研發投資增加以及需要有效藥物開發的慢性病盛行率上升的影響。分子成像以及人工智慧和機器學習的整合存在新的機遇，以增強影像分析和解釋。我們對市場相關人員的建議包括重點關注與學術研究機構的聯合計劃以及擴大影像分析領域的服務範圍。然而，挑戰仍然存在，例如高成本、監管障礙以及動物測試的道德考慮，這些可能會阻礙市場成長。

在技​​術創新方面，開發具成本效益的成像技術和提高影像解析度是主要研究領域。此外，成像系統的小型化和多模態成像解決方案的採用也具有潛力。個人化醫療也存在機會，其中臨床前成像可以顯著有助於識別生物標記和客製化治療方法。臨床前成像市場表現出動態和競爭性，技術進步是差異化的關鍵驅動力。相關人員必須隨時了解最新的技術創新和監管發展，以有效利用新興趨勢實現永續成長。

市場動態：揭示快速發展的臨床前影像市場的關鍵市場洞察

供需的動態交互作用正在改變臨床前影像市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 製藥公司活性化研發活動
    • 增加政府投資和資金以擴大生物醫學研究
    • 臨床研究組織 (CRO) 的增加
  • 市場限制因素
    • 診斷影像設備和臨床前影像的維護成本不斷上升
  • 市場機會
    • 將先進技術更多地整合到臨床前成像中以改進影像分析
    • 個人化醫療的發展日益受到關注
  • 市場挑戰
    • 與動物試驗相關的嚴格法規和道德問題

波特五力：駕馭臨床前影像市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解臨床前影像市場的外部影響

外部宏觀環境因素在塑造臨床前影像市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解臨床前影像市場的競爭格局

對臨床前成像市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣臨床前影像市場供應商績效評估

FPNV定位矩陣是評估臨床前影像市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了臨床前影像市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，臨床前成像市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥公司研發活動增加
      • 增加政府投資和資金以擴大生物醫學研究
      • 臨床研究組織 (CRO) 的增加
    • 抑制因素
      • 影像設備及維護成本高
    • 機會
      • 將先進技術融入臨床前成像以改善影像分析
      • 個人化醫療的發展日益受到關注
    • 任務
      • 與動物研究相關的嚴格法規和道德問題
  • 市場區隔分析
    • 產品：在臨床前研究中增加針對特定研究需求的模式的使用
    • 最終用戶：製藥和生物製藥公司更多地採用臨床前影像來開發新藥
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臨床前影像市場：依產品

  • 情態
    • 磁粒子成像
    • 磁振造影
    • 顯微電腦微電腦
    • 光學成像
    • 正子斷層掃描
    • 單光子發射電腦斷層掃描
  • 試劑
    • 生物發光成像試劑
    • 螢光成像試劑
    • MRI顯影劑
    • PET放射性追蹤劑
    • 超音波顯影劑
    • X光CT顯影劑

第7章臨床前影像市場：依應用分類

  • 藥物發現
  • 研究與開發

第8章臨床前影像市場：依最終使用者分類

  • 學術和政府研究機構
  • 合約研究組織（CRO）
  • 製藥和生物技術公司

第9章美洲臨床前影像市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區臨床前影像市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的臨床前影像市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Revvity, Inc. 在 WMIC 2023 上展示創新的臨床前影像解決方案
  • 戰略分析和建議

公司名單

  • Advanced Molecular Vision, Inc.
  • Angstrom Advanced Inc.
  • Aspect Imaging Ltd.
  • Berthold Technologies
  • Bruker Corporation
  • Euro-BioImaging ERIC
  • FUJIFILM Holdings America Corporation
  • IVIM Technology Corp.
  • KUBTEC Technology
  • LI-COR, Inc.
  • Mediso Ltd.
  • Milabs BV
  • Miltenyi Biotec GmbH
  • MR Solutions Group
  • Peira bvba
  • PerkinElmer Inc.
  • Revvity, Inc.
  • Scitech Pty Ltd.
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-030EE48515D3

The Preclinical Imaging Market was valued at USD 2.48 billion in 2023, expected to reach USD 2.60 billion in 2024, and is projected to grow at a CAGR of 4.91%, to USD 3.48 billion by 2030.

Preclinical imaging is an essential component of the drug development process, often used to study disease models, evaluate drug candidate efficacy, and understand biological processes in vivo. Its scope includes various imaging modalities such as MRI, PET, CT, optical, and ultrasound, providing detailed spatial and temporal data crucial for translational research. The necessity of preclinical imaging lies in its ability to accelerate the drug discovery process by offering high-throughput, quantifiable, non-invasive tools for studying animal models. It is applied across pharmaceutical, biotechnology, and research institutions, primarily serving applications in oncology, neurology, cardiology, and infectious diseases.

KEY MARKET STATISTICS
Base Year [2023] USD 2.48 billion
Estimated Year [2024] USD 2.60 billion
Forecast Year [2030] USD 3.48 billion
CAGR (%) 4.91%

The market growth of preclinical imaging is primarily influenced by advancements in imaging technology, increased investment in R&D, and the rising prevalence of chronic diseases necessitating effective drug development. Emerging opportunities exist in molecular imaging and the integration of AI and machine learning to enhance image analysis and interpretation. Recommendations for market players include focusing on collaborative projects with academic and research institutions and expanding service offerings in image analysis. However, challenges persist, including high costs of equipment and maintenance, regulatory hurdles, and the ethical considerations surrounding animal testing, which could potentially hinder market growth.

In terms of innovation, developing cost-effective imaging technologies and enhancing imaging resolution are prime areas of research. Additionally, there is potential in the miniaturization of imaging systems and the adoption of multi-modal imaging solutions. Businesses can also explore opportunities in personalized medicine, wherein preclinical imaging can significantly contribute to identifying biomarkers and tailoring treatments. The preclinical imaging market exhibits a dynamic and competitive nature, with technological advancements being a key driver for differentiation. Stakeholders must stay abreast of the latest innovations and regulatory landscapes to effectively leverage emerging trends for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Preclinical Imaging Market

The Preclinical Imaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research & development activities by pharmaceutical companies
    • Growing government investment and funding for expanding biomedical research
    • Rising number of clinical research organizations (CROs)
  • Market Restraints
    • High cost of imaging equipment and maintenance of preclinical imaging
  • Market Opportunities
    • Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
    • Rising focus on the development of personalized medicines
  • Market Challenges
    • Strict regulations and ethical concerns associated with animal research

Porter's Five Forces: A Strategic Tool for Navigating the Preclinical Imaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Preclinical Imaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Preclinical Imaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Preclinical Imaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Preclinical Imaging Market

A detailed market share analysis in the Preclinical Imaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Preclinical Imaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Preclinical Imaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Preclinical Imaging Market

A strategic analysis of the Preclinical Imaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Advanced Molecular Vision, Inc., Angstrom Advanced Inc., Aspect Imaging Ltd., Berthold Technologies, Bruker Corporation, Euro-BioImaging ERIC, FUJIFILM Holdings America Corporation, IVIM Technology Corp., KUBTEC Technology, LI-COR, Inc., Mediso Ltd., Milabs BV, Miltenyi Biotec GmbH, MR Solutions Group, Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd., and United Imaging Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Modalities and Reagents. The Modalities is further studied across Magnetic Particle Imaging, Magnetic Resonance Imaging, Micro-Computed Tomography, Optical Imaging, Positron Emission Tomography, and Single-Photon Emission Computed Tomography. The Reagents is further studied across Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents, MRI Contrasting Reagents, PET Radioactive Tracers, Ultrasound Contrasting Reagents, and X-ray CT Contrasting Reagents.
  • Based on Application, market is studied across Drug Discovery and Research & Development.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Contract Research Organizations (CROs), and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research & development activities by pharmaceutical companies
      • 5.1.1.2. Growing government investment and funding for expanding biomedical research
      • 5.1.1.3. Rising number of clinical research organizations (CROs)
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of imaging equipment and maintenance of preclinical imaging
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
      • 5.1.3.2. Rising focus on the development of personalized medicines
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations and ethical concerns associated with animal research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing usage of modalities in preclinical studies for specific research needs
    • 5.2.2. End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Preclinical Imaging Market, by Product

  • 6.1. Introduction
  • 6.2. Modalities
    • 6.2.1. Magnetic Particle Imaging
    • 6.2.2. Magnetic Resonance Imaging
    • 6.2.3. Micro-Computed Tomography
    • 6.2.4. Optical Imaging
    • 6.2.5. Positron Emission Tomography
    • 6.2.6. Single-Photon Emission Computed Tomography
  • 6.3. Reagents
    • 6.3.1. Bioluminescent Imaging Reagents
    • 6.3.2. Fluorescent Imaging Reagents
    • 6.3.3. MRI Contrasting Reagents
    • 6.3.4. PET Radioactive Tracers
    • 6.3.5. Ultrasound Contrasting Reagents
    • 6.3.6. X-ray CT Contrasting Reagents

7. Preclinical Imaging Market, by Application

  • 7.1. Introduction
  • 7.2. Drug Discovery
  • 7.3. Research & Development

8. Preclinical Imaging Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Contract Research Organizations (CROs)
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Preclinical Imaging Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Preclinical Imaging Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Preclinical Imaging Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Revvity, Inc.'s Innovative Preclinical Imaging Solutions Unveiled at WMIC 2023
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Molecular Vision, Inc.
  • 2. Angstrom Advanced Inc.
  • 3. Aspect Imaging Ltd.
  • 4. Berthold Technologies
  • 5. Bruker Corporation
  • 6. Euro-BioImaging ERIC
  • 7. FUJIFILM Holdings America Corporation
  • 8. IVIM Technology Corp.
  • 9. KUBTEC Technology
  • 10. LI-COR, Inc.
  • 11. Mediso Ltd.
  • 12. Milabs BV
  • 13. Miltenyi Biotec GmbH
  • 14. MR Solutions Group
  • 15. Peira bvba
  • 16. PerkinElmer Inc.
  • 17. Revvity, Inc.
  • 18. Scitech Pty Ltd.
  • 19. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PRECLINICAL IMAGING MARKET RESEARCH PROCESS
  • FIGURE 2. PRECLINICAL IMAGING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PRECLINICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PRECLINICAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PRECLINICAL IMAGING MARKET DYNAMICS
  • TABLE 7. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC PARTICLE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MICRO-COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY BIOLUMINESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY FLUORESCENT IMAGING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY MRI CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PET RADIOACTIVE TRACERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ULTRASOUND CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY X-RAY CT CONTRASTING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PRECLINICAL IMAGING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES PRECLINICAL IMAGING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL IMAGING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM PRECLINICAL IMAGING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. PRECLINICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. PRECLINICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023